ALKS
HealthcareAlkermes plc
$27.56-0.08 (-0.29%)
Prev Close
$27.64
Open
$27.88
High
$28.34
Low
$27.41
Volume
1.72M
Market Cap
$4.70B
P/E
—
Div Yield
—
Over the past 12 months, insider activity at Alkermes plc (ALKS) has been exclusively selling, with 0 insider purchases totaling $0.00 and 30 insider sales totaling $8.24M. The most recent insider transaction was by Gaffin David Joseph (EVP, CLO, Alkermes, Inc.), who sold $177.1K worth of shares on Feb 18, 2026. Alkermes plc operates in the Healthcare sector, within the Biotechnology industry, with a market cap of $4.70B.
Buys (12M)
0
$0.00
Sells (12M)
30
$8.24M
Net Activity
Net Seller
$8.24M
Active Insiders
14
last 12 mo
ALKS Price Chart
ALKS Insider Trading Activity
| Date | Insider | Role | Type | Shares | Avg Price | Value | Shares After |
|---|---|---|---|---|---|---|---|
| Feb 18, 2026↗ | Gaffin David Joseph | EVP, CLO, Alkermes, Inc. | Sell | 5,533 | $32.01 | $177.1K | 0 |
| Feb 18, 2026↗ | Hopkinson Craig C. | EVP R&D, Chief Medical Officer | Sell | 6,911 | $32.01 | $221.2K | 0 |
| Feb 18, 2026↗ | Jackson Blair Curtis | EVP, Chief Operating Officer | Sell | 7,926 | $32.01 | $253.7K | 0 |
| Feb 18, 2026↗ | Nichols Christian Todd | SVP, Chief Commercial Officer | Sell | 4,146 | $32.01 | $132.7K | 0 |
| Feb 18, 2026↗ | Parisi Samuel Joseph | VP, Finance (Interim PAO) | Sell | 1,685 | $32.01 | $53.9K | 0 |
| Feb 5, 2026↗ | Gaffin David Joseph | EVP, CLO, Alkermes, Inc. | Sell | 7,619 | $33.55 | $255.6K | 0 |
| Feb 5, 2026↗ | Hopkinson Craig C. | EVP R&D, Chief Medical Officer | Sell | 7,454 | $33.55 | $250.1K | 0 |
| Feb 5, 2026↗ | Jackson Blair Curtis | EVP, Chief Operating Officer | Sell | 8,626 | $33.55 | $289.4K | 0 |
| Feb 5, 2026↗ | Nichols Christian Todd | SVP, Chief Commercial Officer | Sell | 6,389 | $33.55 | $214.4K | 0 |
| Feb 5, 2026↗ | POPS RICHARD F | Director and CEO, Alkermes plc | Sell | 62,230 | $33.55 | $2.09M | 0 |
| Feb 2, 2026↗ | Cooke Shane | Director | Sell | 61,200 | $34.57 | $2.12M | 0 |
| Feb 2, 2026↗ | Hopkinson Craig C. | EVP R&D, Chief Medical Officer | Sell | 9,000 | $33.93 | $305.4K | 0 |
| Jan 8, 2026↗ | Hopkinson Craig C. | EVP R&D, Chief Medical Officer | Sell | 5,000 | $30.00 | $150.0K | 0 |
| Jan 2, 2026↗ | Hopkinson Craig C. | EVP R&D, Chief Medical Officer | Sell | 4,000 | $28.00 | $112.0K | 0 |
| Dec 3, 2025↗ | Hopkinson Craig C. | EVP R&D, Chief Medical Officer | Sell | 3,748 | $30.00 | $112.4K | 0 |
| Dec 1, 2025↗ | Hopkinson Craig C. | EVP R&D, Chief Medical Officer | Sell | 4,000 | $29.30 | $117.2K | 0 |
| Nov 3, 2025↗ | Hopkinson Craig C. | EVP R&D, Chief Medical Officer | Sell | 9,000 | $30.38 | $273.4K | 0 |
| Oct 15, 2025↗ | Hopkinson Craig C. | EVP R&D, Chief Medical Officer | Sell | 9,000 | $31.53 | $283.8K | 0 |
| Aug 3, 2025↗ | Gaffin David Joseph | EVP, CLO, Alkermes, Inc. | Sell | 895 | $26.55 | $23.8K | 0 |
| Jun 9, 2025↗ | Nichols Christian Todd | SVP, Chief Commercial Officer | Sell | 6,667 | $31.52 | $210.1K | 0 |
| Jun 8, 2025↗ | Wright Christopher I | Director | Sell | 793 | $31.71 | $25.1K | 0 |
| May 31, 2025↗ | Cooke Shane | Director | Sell | 4,175 | $30.61 | $127.8K | 0 |
| May 31, 2025↗ | GAYNOR RICHARD | Director | Sell | 1,924 | $30.61 | $58.9K | 0 |
| May 31, 2025↗ | LAURENCIN CATO T | Director | Sell | 1,924 | $30.61 | $58.9K | 0 |
| May 31, 2025↗ | Lurker Nancy | Director | Sell | 1,924 | $30.61 | $58.9K | 0 |
| May 31, 2025↗ | MCKEON BRIAN P | Director | Sell | 1,924 | $30.61 | $58.9K | 0 |
| May 31, 2025↗ | snyderman nancy lynn MD | Director | Sell | 1,924 | $30.61 | $58.9K | 0 |
| May 31, 2025↗ | Wilson Frank Anders | Director | Sell | 1,924 | $30.61 | $58.9K | 0 |
| May 31, 2025↗ | Wright Christopher I | Director | Sell | 1,924 | $30.61 | $58.9K | 0 |
| Apr 11, 2025↗ | Lurker Nancy | Director | Sell | 1,459 | $27.00 | $39.4K | 0 |
| Feb 26, 2025↗ | Brown Iain Michael | SVP, Chief Financial Officer | Sell | 2,494 | $34.79 | $86.8K | 0 |
| Feb 26, 2025↗ | Gaffin David Joseph | EVP, CLO, Alkermes, Inc. | Sell | 3,049 | $34.80 | $106.1K | 0 |
| Feb 26, 2025↗ | Hopkinson Craig C. | EVP R&D, Chief Medical Officer | Sell | 3,049 | $34.80 | $106.1K | 0 |
| Feb 26, 2025↗ | Jackson Blair Curtis | EVP, Chief Operating Officer | Sell | 3,695 | $34.80 | $128.6K | 0 |
| Feb 26, 2025↗ | Nichols Christian Todd | SVP, Chief Commercial Officer | Sell | 2,402 | $34.80 | $83.6K | 0 |
| Feb 26, 2025↗ | Parisi Samuel Joseph | VP, Finance (Interim PAO) | Sell | 2,746 | $34.23 | $94.0K | 0 |
| Feb 22, 2025↗ | Brown Iain Michael | SVP, Chief Financial Officer | Sell | 5,741 | $35.32 | $202.8K | 0 |
| Feb 22, 2025↗ | Gaffin David Joseph | EVP, CLO, Alkermes, Inc. | Sell | 6,714 | $35.32 | $237.1K | 0 |
| Feb 22, 2025↗ | Hopkinson Craig C. | EVP R&D, Chief Medical Officer | Sell | 8,866 | $35.32 | $313.1K | 0 |
| Feb 22, 2025↗ | Jackson Blair Curtis | EVP, Chief Operating Officer | Sell | 8,185 | $35.32 | $289.1K | 0 |
| Feb 22, 2025↗ | Nichols Christian Todd | SVP, Chief Commercial Officer | Sell | 6,003 | $35.32 | $212.0K | 0 |
| Feb 22, 2025↗ | Parisi Samuel Joseph | VP, Finance (Interim PAO) | Sell | 5,398 | $35.28 | $190.4K | 0 |
| Feb 18, 2025↗ | Brown Iain Michael | SVP, Chief Financial Officer | Sell | 1,869 | $35.90 | $67.1K | 0 |
| Feb 18, 2025↗ | Gaffin David Joseph | EVP, CLO, Alkermes, Inc. | Sell | 2,822 | $35.90 | $101.3K | 0 |
| Feb 18, 2025↗ | Hopkinson Craig C. | EVP R&D, Chief Medical Officer | Sell | 3,950 | $35.90 | $141.8K | 0 |
| Feb 18, 2025↗ | Jackson Blair Curtis | EVP, Chief Operating Officer | Sell | 3,950 | $35.90 | $141.8K | 0 |
| Feb 18, 2025↗ | Nichols Christian Todd | SVP, Chief Commercial Officer | Sell | 1,869 | $35.90 | $67.1K | 0 |
| Feb 18, 2025↗ | Parisi Samuel Joseph | VP, Finance (Interim PAO) | Sell | 2,033 | $35.76 | $72.7K | 0 |
| Feb 12, 2025↗ | Hopkinson Craig C. | EVP R&D, Chief Medical Officer | Sell | 349,340 | $33.92 | $11.85M | 0 |
| Feb 6, 2025↗ | Brown Iain Michael | SVP, Chief Financial Officer | Sell | 7,514 | $31.39 | $235.9K | 0 |
| Feb 6, 2025↗ | Gaffin David Joseph | EVP, CLO, Alkermes, Inc. | Sell | 9,752 | $31.39 | $306.1K | 0 |
| Feb 6, 2025↗ | Hopkinson Craig C. | EVP R&D, Chief Medical Officer | Sell | 15,083 | $31.39 | $473.5K | 0 |
| Feb 6, 2025↗ | Jackson Blair Curtis | EVP, Chief Operating Officer | Sell | 10,647 | $31.39 | $334.2K | 0 |
| Feb 6, 2025↗ | Nichols Christian Todd | SVP, Chief Commercial Officer | Sell | 7,399 | $31.39 | $232.3K | 0 |
| Feb 6, 2025↗ | POPS RICHARD F | Director and CEO, Alkermes plc | Sell | 79,925 | $31.39 | $2.51M | 0 |
| Jan 30, 2025↗ | Hopkinson Craig C. | EVP R&D, Chief Medical Officer | Sell | 100,918 | $32.05 | $3.23M | 0 |
| Dec 9, 2024↗ | Hopkinson Craig C. | EVP R&D, Chief Medical Officer | Sell | 61,151 | $32.07 | $1.96M | 0 |
| Dec 8, 2024↗ | LAURENCIN CATO T | Director | Sell | 3,649 | $31.75 | $115.8K | 0 |
| Dec 5, 2024↗ | Hopkinson Craig C. | EVP R&D, Chief Medical Officer | Sell | 9,221 | $31.50 | $290.5K | 0 |
| Dec 4, 2024↗ | Hopkinson Craig C. | EVP R&D, Chief Medical Officer | Sell | 14,349 | $30.77 | $441.6K | 0 |
| Nov 27, 2024↗ | Nichols Christian Todd | SVP, Chief Commercial Officer | Sell | 5,208 | $29.15 | $151.8K | 0 |
| Nov 11, 2024↗ | Hopkinson Craig C. | EVP R&D, Chief Medical Officer | Sell | 58,996 | $30.08 | $1.77M | 0 |
| Nov 6, 2024↗ | Hopkinson Craig C. | EVP R&D, Chief Medical Officer | Sell | 10,471 | $29.53 | $309.2K | 0 |
| Aug 3, 2024↗ | Gaffin David Joseph | EVP, CLO, Alkermes, Inc. | Sell | 895 | $27.72 | $24.8K | 0 |
| Jun 29, 2024↗ | Alva Emily Peterson | Director | Sell | 1,465 | $24.10 | $35.3K | 0 |
| Jun 29, 2024↗ | Cooke Shane | Director | Sell | 3,175 | $24.10 | $76.5K | 0 |
| Jun 29, 2024↗ | Daglio David Angelo Jr. | Director | Sell | 1,465 | $24.10 | $35.3K | 0 |
| Jun 29, 2024↗ | GAYNOR RICHARD | Director | Sell | 1,465 | $24.10 | $35.3K | 0 |
| Jun 29, 2024↗ | LAURENCIN CATO T | Director | Sell | 1,465 | $24.10 | $35.3K | 0 |
| Jun 29, 2024↗ | MCKEON BRIAN P | Director | Sell | 1,465 | $24.10 | $35.3K | 0 |
| Jun 29, 2024↗ | snyderman nancy lynn MD | Director | Sell | 1,465 | $24.10 | $35.3K | 0 |
| Jun 29, 2024↗ | Wilson Frank Anders | Director | Sell | 1,465 | $24.10 | $35.3K | 0 |
| Jun 29, 2024↗ | Wright Christopher I | Director | Sell | 1,465 | $24.10 | $35.3K | 0 |
| Jun 9, 2024↗ | Alva Emily Peterson | Director | Sell | 930 | $23.91 | $22.2K | 0 |
| Jun 8, 2024↗ | Wright Christopher I | Director | Sell | 793 | $23.91 | $19.0K | 0 |
| Mar 18, 2024↗ | Nichols Christian Todd | SVP, Chief Commercial Officer | Sell | 10,417 | $28.10 | $292.7K | 0 |
| Feb 23, 2024↗ | Brown Iain Michael | SVP, Chief Financial Officer | Sell | 2,587 | $29.57 | $76.5K | 0 |
| Feb 23, 2024↗ | Gaffin David Joseph | EVP, CLO, Alkermes, Inc. | Sell | 3,414 | $29.57 | $101.0K | 0 |
| Feb 23, 2024↗ | Hopkinson Craig C. | EVP R&D, Chief Medical Officer | Sell | 3,414 | $29.57 | $101.0K | 0 |
| Feb 23, 2024↗ | Jackson Blair Curtis | EVP, Chief Operating Officer | Sell | 3,880 | $29.57 | $114.7K | 0 |
| Feb 23, 2024↗ | LANDINE MICHAEL J | SVP, Corp Dev., Alkermes, Inc. | Sell | 1,811 | $29.57 | $53.6K | 0 |
| Feb 23, 2024↗ | Nichols Christian Todd | SVP, Chief Commercial Officer | Sell | 2,845 | $29.57 | $84.1K | 0 |
| Feb 23, 2024↗ | Parisi Samuel Joseph | VP, Finance (Interim PAO) | Sell | 3,231 | $29.63 | $95.7K | 0 |
| Feb 22, 2024↗ | Brown Iain Michael | SVP, Chief Financial Officer | Sell | 3,156 | $28.91 | $91.2K | 0 |
| Feb 22, 2024↗ | Gaffin David Joseph | EVP, CLO, Alkermes, Inc. | Sell | 3,300 | $28.91 | $95.4K | 0 |
| Feb 22, 2024↗ | Hopkinson Craig C. | EVP R&D, Chief Medical Officer | Sell | 5,452 | $28.91 | $157.6K | 0 |
| Feb 22, 2024↗ | Jackson Blair Curtis | EVP, Chief Operating Officer | Sell | 4,304 | $28.91 | $124.4K | 0 |
| Feb 22, 2024↗ | LANDINE MICHAEL J | SVP, Corp Dev., Alkermes, Inc. | Sell | 1,929 | $28.91 | $55.8K | 0 |
| Feb 22, 2024↗ | Nichols Christian Todd | SVP, Chief Commercial Officer | Sell | 3,156 | $28.91 | $91.2K | 0 |
| Feb 22, 2024↗ | Parisi Samuel Joseph | VP, Finance (Interim PAO) | Sell | 908 | $28.91 | $26.3K | 0 |
| Feb 18, 2024↗ | Brown Iain Michael | SVP, Chief Financial Officer | Sell | 3,594 | $31.32 | $112.6K | 0 |
| Feb 18, 2024↗ | Gaffin David Joseph | EVP, CLO, Alkermes, Inc. | Sell | 4,863 | $31.08 | $151.1K | 0 |
| Feb 18, 2024↗ | Hopkinson Craig C. | EVP R&D, Chief Medical Officer | Sell | 8,523 | $31.22 | $266.1K | 0 |
| Feb 18, 2024↗ | Jackson Blair Curtis | EVP, Chief Operating Officer | Sell | 5,966 | $31.56 | $188.3K | 0 |
| Feb 18, 2024↗ | LANDINE MICHAEL J | SVP, Corp Dev., Alkermes, Inc. | Sell | 2,914 | $31.19 | $90.9K | 0 |
| Feb 18, 2024↗ | Nichols Christian Todd | SVP, Chief Commercial Officer | Sell | 3,248 | $31.42 | $102.1K | 0 |
| Feb 18, 2024↗ | Parisi Samuel Joseph | VP, Finance (Interim PAO) | Sell | 1,347 | $31.33 | $42.2K | 0 |
| Feb 15, 2024↗ | LAURENCIN CATO T | Director | Sell | 2,690 | $31.85 | $85.7K | 0 |
| Feb 10, 2024↗ | Daglio David Angelo Jr. | Director | Sell | 1,088 | $27.32 | $29.7K | 0 |
| Feb 10, 2024↗ | MCKEON BRIAN P | Director | Sell | 1,088 | $27.32 | $29.7K | 0 |
| Feb 8, 2024↗ | Brown Iain Michael | SVP, Chief Financial Officer | Sell | 8,137 | $26.77 | $217.8K | 0 |
| Feb 8, 2024↗ | Gaffin David Joseph | EVP, CLO, Alkermes, Inc. | Sell | 8,483 | $26.77 | $227.1K | 0 |
| Feb 8, 2024↗ | Hopkinson Craig C. | EVP R&D, Chief Medical Officer | Sell | 15,280 | $26.77 | $409.0K | 0 |
| Feb 8, 2024↗ | Jackson Blair Curtis | EVP, Chief Operating Officer | Sell | 11,007 | $26.77 | $294.7K | 0 |
| Feb 8, 2024↗ | LANDINE MICHAEL J | SVP, Corp Dev., Alkermes, Inc. | Sell | 3,183 | $26.77 | $85.2K | 0 |
| Feb 8, 2024↗ | Nichols Christian Todd | SVP, Chief Commercial Officer | Sell | 8,135 | $26.77 | $217.8K | 0 |
| Feb 8, 2024↗ | POPS RICHARD F | Director and CEO, Alkermes plc | Sell | 91,757 | $26.77 | $2.46M | 0 |
| Dec 8, 2023↗ | LAURENCIN CATO T | Director | Sell | 1,000 | $25.86 | $25.9K | 0 |
| Aug 3, 2023↗ | Gaffin David Joseph | EVP, CLO, Alkermes, Inc. | Sell | 877 | $27.63 | $24.2K | 0 |
| Jul 7, 2023↗ | Alva Emily Peterson | Director | Sell | 1,430 | $29.88 | $42.7K | 0 |
| Jul 7, 2023↗ | Cooke Shane | Director | Sell | 3,098 | $29.88 | $92.6K | 0 |
| Jul 7, 2023↗ | Daglio David Angelo Jr. | Director | Sell | 1,430 | $29.88 | $42.7K | 0 |
| Jul 7, 2023↗ | GAYNOR RICHARD | Director | Sell | 1,430 | $29.88 | $42.7K | 0 |
| Jul 7, 2023↗ | LAURENCIN CATO T | Director | Sell | 1,430 | $29.88 | $42.7K | 0 |
| Jul 7, 2023↗ | MCKEON BRIAN P | Director | Sell | 1,430 | $29.88 | $42.7K | 0 |
| Jul 7, 2023↗ | snyderman nancy lynn MD | Director | Sell | 1,430 | $29.88 | $42.7K | 0 |
| Jul 7, 2023↗ | Wilson Frank Anders | Director | Sell | 1,430 | $29.88 | $42.7K | 0 |
| Jul 7, 2023↗ | Wright Christopher I | Director | Sell | 1,430 | $29.88 | $42.7K | 0 |
| Jul 7, 2023↗ | Wysenski Nancy | Director | Sell | 1,430 | $29.88 | $42.7K | 0 |
| Jun 9, 2023↗ | Alva Emily Peterson | Director | Sell | 911 | $31.13 | $28.4K | 0 |
| Jun 8, 2023↗ | LAURENCIN CATO T | Director | Sell | 2,638 | $31.85 | $84.0K | 0 |
| Jun 8, 2023↗ | Wright Christopher I | Director | Sell | 867 | $31.54 | $27.3K | 0 |
| Jun 7, 2023↗ | LAURENCIN CATO T | Director | Sell | 2,800 | $31.50 | $88.2K | 0 |
| Jun 5, 2023↗ | Nichols Christian Todd | SVP, Chief Commercial Officer | Sell | 1,555 | $29.46 | $45.8K | 0 |
| May 30, 2023↗ | Nichols Christian Todd | SVP, Chief Commercial Officer | Sell | 27,134 | $28.93 | $784.9K | 0 |
| May 9, 2023↗ | Wysenski Nancy | Director | Sell | 41,250 | $31.24 | $1.29M | 0 |
| Feb 22, 2023↗ | Brown Iain Michael | SVP, Chief Financial Officer | Sell | 2,049 | $27.77 | $56.9K | 0 |
| Feb 22, 2023↗ | Gaffin David Joseph | EVP, CLO, Alkermes, Inc. | Sell | 3,224 | $27.77 | $89.5K | 0 |
| Feb 22, 2023↗ | Hopkinson Craig C. | EVP R&D, Chief Medical Officer | Sell | 5,345 | $27.77 | $148.4K | 0 |
| Feb 22, 2023↗ | Jackson Blair Curtis | EVP, Chief Operating Officer | Sell | 3,088 | $27.77 | $85.8K | 0 |
| Feb 22, 2023↗ | LANDINE MICHAEL J | SVP, Corp Dev., Alkermes, Inc. | Sell | 2,462 | $27.77 | $68.4K | 0 |
| Feb 22, 2023↗ | Nichols Christian Todd | SVP, Chief Commercial Officer | Sell | 2,704 | $27.77 | $75.1K | 0 |
| Feb 20, 2023↗ | POPS RICHARD F | Director and CEO, Alkermes plc | Sell | 67,531 | $28.01 | $1.89M | 0 |
| Feb 18, 2023↗ | Brown Iain Michael | SVP, Chief Financial Officer | Sell | 7,693 | $28.01 | $215.5K | 0 |
| Feb 18, 2023↗ | Gaffin David Joseph | EVP, CLO, Alkermes, Inc. | Sell | 10,584 | $28.01 | $296.5K | 0 |
| Feb 18, 2023↗ | Hopkinson Craig C. | EVP R&D, Chief Medical Officer | Sell | 16,015 | $28.01 | $448.6K | 0 |
| Feb 18, 2023↗ | Jackson Blair Curtis | EVP, Chief Operating Officer | Sell | 8,411 | $28.02 | $235.7K | 0 |
| Feb 18, 2023↗ | LANDINE MICHAEL J | SVP, Corp Dev., Alkermes, Inc. | Sell | 12,256 | $28.01 | $343.3K | 0 |
| Feb 18, 2023↗ | Nichols Christian Todd | SVP, Chief Commercial Officer | Sell | 9,839 | $28.07 | $276.2K | 0 |
| Dec 8, 2022↗ | LAURENCIN CATO T | Director | Sell | 763 | $25.48 | $19.4K | 0 |
| Nov 14, 2022↗ | Daglio David Angelo Jr. | Director | Buy | 35,000 | $23.31 | $815.7K | 0 |
| Jun 21, 2022↗ | Nichols Christian Todd | SVP, Chief Commercial Officer | Sell | 7,474 | $28.26 | $211.2K | 0 |
| Jun 14, 2022↗ | Alva Emily Peterson | Director | Sell | 905 | $27.19 | $24.6K | 0 |
| Jun 14, 2022↗ | Cooke Shane | Director | Sell | 3,945 | $27.19 | $107.3K | 0 |
| Jun 14, 2022↗ | Daglio David Angelo Jr. | Director | Sell | 795 | $27.19 | $21.6K | 0 |
| Jun 14, 2022↗ | GAYNOR RICHARD | Director | Sell | 695 | $27.19 | $18.9K | 0 |
| Jun 14, 2022↗ | MCKEON BRIAN P | Director | Sell | 795 | $27.19 | $21.6K | 0 |
| Jun 14, 2022↗ | snyderman nancy lynn MD | Director | Sell | 695 | $27.19 | $18.9K | 0 |
| Jun 14, 2022↗ | Wilson Frank Anders | Director | Sell | 695 | $27.19 | $18.9K | 0 |
| Jun 14, 2022↗ | Wysenski Nancy | Director | Sell | 695 | $27.19 | $18.9K | 0 |
| Jun 9, 2022↗ | Alva Emily Peterson | Director | Sell | 347 | $28.13 | $9.8K | 0 |
| Jun 5, 2022↗ | Nichols Christian Todd | SVP, Chief Commercial Officer | Sell | 1,029 | $29.31 | $30.2K | 0 |
| May 17, 2022↗ | LANDINE MICHAEL J | SVP, Corp Dev., Alkermes, Inc. | Sell | 50,000 | $29.15 | $1.46M | 0 |
| May 10, 2022↗ | LANDINE MICHAEL J | SVP, Corp Dev., Alkermes, Inc. | Sell | 25,000 | $27.22 | $680.4K | 0 |
| May 5, 2022↗ | POPS RICHARD F | Director and CEO, Alkermes plc | Sell | 347,257 | $27.98 | $9.72M | 0 |
| May 3, 2022↗ | LANDINE MICHAEL J | SVP, Corp Dev., Alkermes, Inc. | Sell | 25,000 | $28.62 | $715.4K | 0 |
| May 2, 2022↗ | Cooke Shane | Director | Sell | 10,000 | $29.23 | $292.3K | 0 |
| Apr 25, 2022↗ | Cooke Shane | Director | Sell | 10,000 | $27.88 | $278.8K | 0 |
| Apr 20, 2022↗ | Jackson Blair Curtis | EVP, Chief Operating Officer | Sell | 49,999 | $29.61 | $1.48M | 0 |
| Apr 18, 2022↗ | Cooke Shane | Director | Sell | 10,000 | $28.88 | $288.8K | 0 |
| Apr 11, 2022↗ | Cooke Shane | Director | Sell | 10,000 | $29.26 | $292.6K | 0 |
| Apr 4, 2022↗ | Cooke Shane | Director | Sell | 10,000 | $28.18 | $281.8K | 0 |
| Mar 4, 2022↗ | snyderman nancy lynn MD | Director | Buy | 427 | $23.43 | $10.0K | 0 |
| Feb 23, 2022↗ | Hopkinson Craig C. | EVP R&D, Chief Medical Officer | Sell | 11,983 | $24.76 | $296.6K | 0 |
| Feb 18, 2022↗ | Brown Iain Michael | SVP, Chief Financial Officer | Sell | 4,809 | $25.05 | $120.5K | 0 |
| Feb 18, 2022↗ | Gaffin David Joseph | SVP, CLO, Alkermes, Inc. | Sell | 6,226 | $25.06 | $156.0K | 0 |
| Feb 18, 2022↗ | Hopkinson Craig C. | EVP R&D, Chief Medical Officer | Sell | 10,833 | $25.08 | $271.7K | 0 |
| Feb 18, 2022↗ | Jackson Blair Curtis | EVP, Chief Operating Officer | Sell | 5,541 | $25.04 | $138.8K | 0 |
| Feb 18, 2022↗ | LANDINE MICHAEL J | SVP, Corp Dev., Alkermes, Inc. | Sell | 7,417 | $25.06 | $185.8K | 0 |
| Feb 18, 2022↗ | Nichols Christian Todd | SVP, Chief Commercial Officer | Sell | 3,293 | $25.04 | $82.4K | 0 |
| Feb 18, 2022↗ | POPS RICHARD F | Director and CEO, Alkermes plc | Sell | 14,386 | $25.08 | $360.8K | 0 |
| Feb 16, 2022↗ | Brown Iain Michael | SVP, Chief Financial Officer | Sell | 825 | $26.79 | $22.1K | 0 |
| Feb 16, 2022↗ | Gaffin David Joseph | SVP, CLO, Alkermes, Inc. | Sell | 1,098 | $26.79 | $29.4K | 0 |
| Feb 16, 2022↗ | Hopkinson Craig C. | EVP R&D, Chief Medical Officer | Sell | 1,069 | $26.79 | $28.6K | 0 |
| Feb 16, 2022↗ | Jackson Blair Curtis | EVP, Chief Operating Officer | Sell | 825 | $26.79 | $22.1K | 0 |
| Feb 16, 2022↗ | LANDINE MICHAEL J | SVP, Corp Dev., Alkermes, Inc. | Sell | 1,620 | $26.79 | $43.4K | 0 |
| Feb 16, 2022↗ | POPS RICHARD F | Director and CEO, Alkermes plc | Sell | 8,038 | $26.79 | $215.3K | 0 |
| Feb 10, 2022↗ | Daglio David Angelo Jr. | Director | Sell | 2,735 | $23.55 | $64.4K | 0 |
| Feb 10, 2022↗ | MCKEON BRIAN P | Director | Sell | 2,735 | $23.55 | $64.4K | 0 |
| Dec 2, 2021↗ | ANSTICE DAVID W | Director | Sell | 1,339 | $22.11 | $29.6K | 0 |
| Dec 2, 2021↗ | Cooke Shane | Director | Sell | 2,901 | $22.11 | $64.1K | 0 |
| Dec 2, 2021↗ | DIXON WENDY L | Director | Sell | 1,339 | $22.11 | $29.6K | 0 |
| Dec 2, 2021↗ | GAYNOR RICHARD | Director | Sell | 1,339 | $22.11 | $29.6K | 0 |
| Dec 2, 2021↗ | snyderman nancy lynn MD | Director | Sell | 1,339 | $22.11 | $29.6K | 0 |
| Dec 2, 2021↗ | Wilson Frank Anders | Director | Sell | 1,339 | $22.11 | $29.6K | 0 |
| Dec 2, 2021↗ | Wysenski Nancy | Director | Sell | 1,339 | $22.11 | $29.6K | 0 |
| Sep 14, 2021↗ | Brown Iain Michael | SVP, Chief Financial Officer | Sell | 3,057 | $30.60 | $93.5K | 0 |
| Sep 14, 2021↗ | Gaffin David Joseph | SVP, CLO, Alkermes, Inc. | Sell | 4,634 | $30.60 | $141.8K | 0 |
| Sep 14, 2021↗ | Hopkinson Craig C. | EVP R&D, Chief Medical Officer | Sell | 5,647 | $30.60 | $172.8K | 0 |
| Sep 14, 2021↗ | Jackson Blair Curtis | EVP, Chief Operating Officer | Sell | 2,024 | $30.60 | $61.9K | 0 |
| Sep 14, 2021↗ | LANDINE MICHAEL J | SVP, Corp Dev., Alkermes, Inc. | Sell | 3,566 | $30.60 | $109.1K | 0 |
| Sep 14, 2021↗ | Nichols Christian Todd | SVP, Chief Commercial Officer | Sell | 4,608 | $30.60 | $141.0K | 0 |
| Sep 14, 2021↗ | POPS RICHARD F | Director and CEO, Alkermes plc | Sell | 36,267 | $30.60 | $1.11M | 0 |
| Aug 23, 2021↗ | Alva Emily Peterson | Director | Buy | 1,650 | $30.22 | $49.9K | 0 |
| Aug 19, 2021↗ | Brown Iain Michael | SVP, Chief Financial Officer | Sell | 40,000 | $29.99 | $1.20M | 0 |
| Aug 2, 2021↗ | MCKEON BRIAN P | Director | Buy | 10,000 | $26.43 | $264.3K | 0 |
| Jul 29, 2021↗ | Gaffin David Joseph | SVP, CLO, Alkermes, Inc. | Sell | 14,000 | $26.00 | $364.0K | 0 |
| Jul 1, 2021↗ | ANSTICE DAVID W | Director | Sell | 20,000 | $24.58 | $491.5K | 0 |
| Jun 10, 2021↗ | DIXON WENDY L | Director | Sell | 25,000 | $25.00 | $625.0K | 0 |
| Jun 10, 2021↗ | Gaffin David Joseph | SVP, CLO, Alkermes, Inc. | Sell | 13,500 | $25.00 | $337.5K | 0 |
| Jun 9, 2021↗ | Hopkinson Craig C. | EVP R&D, Chief Medical Officer | Sell | 882 | $24.60 | $21.7K | 0 |
| Jun 7, 2021↗ | ANSTICE DAVID W | Director | Sell | 5,000 | $24.00 | $120.0K | 0 |
| Jun 7, 2021↗ | Gaffin David Joseph | SVP, CLO, Alkermes, Inc. | Sell | 13,500 | $24.00 | $324.0K | 0 |
| Jun 7, 2021↗ | Hopkinson Craig C. | EVP R&D, Chief Medical Officer | Sell | 368 | $23.50 | $8.6K | 0 |
| Jun 5, 2021↗ | Nichols Christian Todd | SVP, Chief Commercial Officer | Sell | 1,029 | $23.08 | $23.7K | 0 |
| May 20, 2021↗ | ANSTICE DAVID W | Director | Sell | 1,404 | $21.92 | $30.8K | 0 |
| May 20, 2021↗ | BREYER ROBERT A | Director | Sell | 2,930 | $21.92 | $64.2K | 0 |
| May 20, 2021↗ | Cooke Shane | Director | Sell | 3,175 | $21.92 | $69.6K | 0 |
| May 20, 2021↗ | DIXON WENDY L | Director | Sell | 1,404 | $21.92 | $30.8K | 0 |
| May 20, 2021↗ | GAYNOR RICHARD | Director | Sell | 1,404 | $21.92 | $30.8K | 0 |
| May 20, 2021↗ | MITCHELL PAUL J | Director | Sell | 2,930 | $21.92 | $64.2K | 0 |
| May 20, 2021↗ | snyderman nancy lynn MD | Director | Sell | 1,404 | $21.92 | $30.8K | 0 |
| May 20, 2021↗ | Wilson Frank Anders | Director | Sell | 1,404 | $21.92 | $30.8K | 0 |
| May 20, 2021↗ | Wysenski Nancy | Director | Sell | 1,404 | $21.92 | $30.8K | 0 |
| May 18, 2021↗ | POPS RICHARD F | Director and CEO, Alkermes plc | Sell | 150,000 | $21.90 | $3.29M | 0 |
| May 17, 2021↗ | LANDINE MICHAEL J | SVP, Corp Dev., Alkermes, Inc. | Sell | 50,000 | $22.09 | $1.10M | 0 |
| May 14, 2021↗ | Gaffin David Joseph | SVP, CLO, Alkermes, Inc. | Sell | 2,250 | $22.23 | $50.0K | 0 |
| May 13, 2021↗ | LANDINE MICHAEL J | SVP, Corp Dev., Alkermes, Inc. | Sell | 25,000 | $22.39 | $559.7K | 0 |
| May 11, 2021↗ | POPS RICHARD F | Director and CEO, Alkermes plc | Sell | 150,000 | $22.09 | $3.31M | 0 |
| May 7, 2021↗ | LANDINE MICHAEL J | SVP, Corp Dev., Alkermes, Inc. | Sell | 19,477 | $22.10 | $430.5K | 0 |
| May 6, 2021↗ | POPS RICHARD F | Director and CEO, Alkermes plc | Sell | 100,000 | $21.79 | $2.18M | 0 |
| May 3, 2021↗ | Jackson Blair Curtis | EVP, Chief Operating Officer | Sell | 34,503 | $22.18 | $765.2K | 0 |
| Apr 19, 2021↗ | DIXON WENDY L | Director | Sell | 25,000 | $20.00 | $500.1K | 0 |
| Apr 16, 2021↗ | Brown Iain Michael | SVP, Chief Financial Officer | Sell | 35,000 | $20.00 | $699.9K | 0 |
| Apr 15, 2021↗ | Hopkinson Craig C. | EVP R&D, Chief Medical Officer | Sell | 28,920 | $19.72 | $570.3K | 0 |
| Feb 21, 2021↗ | POPS RICHARD F | Director and CEO, Alkermes plc | Sell | 14,386 | $19.58 | $281.7K | 0 |
| Feb 20, 2021↗ | Brown Iain Michael | SVP, Chief Financial Officer | Sell | 2,790 | $19.58 | $54.6K | 0 |
| Feb 20, 2021↗ | Gaffin David Joseph | SVP, CLO, Alkermes, Inc. | Sell | 4,083 | $19.58 | $79.9K | 0 |
| Feb 20, 2021↗ | Hopkinson Craig C. | EVP R&D, Chief Medical Officer | Sell | 5,086 | $19.58 | $99.6K | 0 |
| Feb 20, 2021↗ | Jackson Blair Curtis | EVP, Chief Operating Officer | Sell | 2,786 | $19.58 | $54.5K | 0 |
| Feb 20, 2021↗ | LANDINE MICHAEL J | SVP, Corp Dev., Alkermes, Inc. | Sell | 4,947 | $19.58 | $96.9K | 0 |
| Feb 20, 2021↗ | Nichols Christian Todd | SVP, Chief Commercial Officer | Sell | 1,292 | $19.58 | $25.3K | 0 |
ALKS Insider Buying Activity
The following table shows recent insider purchases of Alkermes plc (ALKS) stock reported via SEC Form 4 filings.
| Date | Insider | Role | Type | Shares | Avg Price | Value | Shares After |
|---|---|---|---|---|---|---|---|
| Nov 14, 2022↗ | Daglio David Angelo Jr. | Director | Buy | 35,000 | $23.31 | $815.7K | 0 |
| Mar 4, 2022↗ | snyderman nancy lynn MD | Director | Buy | 427 | $23.43 | $10.0K | 0 |
| Aug 23, 2021↗ | Alva Emily Peterson | Director | Buy | 1,650 | $30.22 | $49.9K | 0 |
| Aug 2, 2021↗ | MCKEON BRIAN P | Director | Buy | 10,000 | $26.43 | $264.3K | 0 |
ALKS Insider Selling Activity
The following table shows recent insider sales of Alkermes plc (ALKS) stock reported via SEC Form 4 filings.
| Date | Insider | Role | Type | Shares | Avg Price | Value | Shares After |
|---|---|---|---|---|---|---|---|
| Feb 18, 2026↗ | Gaffin David Joseph | EVP, CLO, Alkermes, Inc. | Sell | 5,533 | $32.01 | $177.1K | 0 |
| Feb 18, 2026↗ | Hopkinson Craig C. | EVP R&D, Chief Medical Officer | Sell | 6,911 | $32.01 | $221.2K | 0 |
| Feb 18, 2026↗ | Jackson Blair Curtis | EVP, Chief Operating Officer | Sell | 7,926 | $32.01 | $253.7K | 0 |
| Feb 18, 2026↗ | Nichols Christian Todd | SVP, Chief Commercial Officer | Sell | 4,146 | $32.01 | $132.7K | 0 |
| Feb 18, 2026↗ | Parisi Samuel Joseph | VP, Finance (Interim PAO) | Sell | 1,685 | $32.01 | $53.9K | 0 |
| Feb 5, 2026↗ | Gaffin David Joseph | EVP, CLO, Alkermes, Inc. | Sell | 7,619 | $33.55 | $255.6K | 0 |
| Feb 5, 2026↗ | Hopkinson Craig C. | EVP R&D, Chief Medical Officer | Sell | 7,454 | $33.55 | $250.1K | 0 |
| Feb 5, 2026↗ | Jackson Blair Curtis | EVP, Chief Operating Officer | Sell | 8,626 | $33.55 | $289.4K | 0 |
| Feb 5, 2026↗ | Nichols Christian Todd | SVP, Chief Commercial Officer | Sell | 6,389 | $33.55 | $214.4K | 0 |
| Feb 5, 2026↗ | POPS RICHARD F | Director and CEO, Alkermes plc | Sell | 62,230 | $33.55 | $2.09M | 0 |
| Feb 2, 2026↗ | Cooke Shane | Director | Sell | 61,200 | $34.57 | $2.12M | 0 |
| Feb 2, 2026↗ | Hopkinson Craig C. | EVP R&D, Chief Medical Officer | Sell | 9,000 | $33.93 | $305.4K | 0 |
| Jan 8, 2026↗ | Hopkinson Craig C. | EVP R&D, Chief Medical Officer | Sell | 5,000 | $30.00 | $150.0K | 0 |
| Jan 2, 2026↗ | Hopkinson Craig C. | EVP R&D, Chief Medical Officer | Sell | 4,000 | $28.00 | $112.0K | 0 |
| Dec 3, 2025↗ | Hopkinson Craig C. | EVP R&D, Chief Medical Officer | Sell | 3,748 | $30.00 | $112.4K | 0 |
| Dec 1, 2025↗ | Hopkinson Craig C. | EVP R&D, Chief Medical Officer | Sell | 4,000 | $29.30 | $117.2K | 0 |
| Nov 3, 2025↗ | Hopkinson Craig C. | EVP R&D, Chief Medical Officer | Sell | 9,000 | $30.38 | $273.4K | 0 |
| Oct 15, 2025↗ | Hopkinson Craig C. | EVP R&D, Chief Medical Officer | Sell | 9,000 | $31.53 | $283.8K | 0 |
| Aug 3, 2025↗ | Gaffin David Joseph | EVP, CLO, Alkermes, Inc. | Sell | 895 | $26.55 | $23.8K | 0 |
| Jun 9, 2025↗ | Nichols Christian Todd | SVP, Chief Commercial Officer | Sell | 6,667 | $31.52 | $210.1K | 0 |
| Jun 8, 2025↗ | Wright Christopher I | Director | Sell | 793 | $31.71 | $25.1K | 0 |
| May 31, 2025↗ | Cooke Shane | Director | Sell | 4,175 | $30.61 | $127.8K | 0 |
| May 31, 2025↗ | GAYNOR RICHARD | Director | Sell | 1,924 | $30.61 | $58.9K | 0 |
| May 31, 2025↗ | LAURENCIN CATO T | Director | Sell | 1,924 | $30.61 | $58.9K | 0 |
| May 31, 2025↗ | Lurker Nancy | Director | Sell | 1,924 | $30.61 | $58.9K | 0 |
| May 31, 2025↗ | MCKEON BRIAN P | Director | Sell | 1,924 | $30.61 | $58.9K | 0 |
| May 31, 2025↗ | snyderman nancy lynn MD | Director | Sell | 1,924 | $30.61 | $58.9K | 0 |
| May 31, 2025↗ | Wilson Frank Anders | Director | Sell | 1,924 | $30.61 | $58.9K | 0 |
| May 31, 2025↗ | Wright Christopher I | Director | Sell | 1,924 | $30.61 | $58.9K | 0 |
| Apr 11, 2025↗ | Lurker Nancy | Director | Sell | 1,459 | $27.00 | $39.4K | 0 |
| Feb 26, 2025↗ | Brown Iain Michael | SVP, Chief Financial Officer | Sell | 2,494 | $34.79 | $86.8K | 0 |
| Feb 26, 2025↗ | Gaffin David Joseph | EVP, CLO, Alkermes, Inc. | Sell | 3,049 | $34.80 | $106.1K | 0 |
| Feb 26, 2025↗ | Hopkinson Craig C. | EVP R&D, Chief Medical Officer | Sell | 3,049 | $34.80 | $106.1K | 0 |
| Feb 26, 2025↗ | Jackson Blair Curtis | EVP, Chief Operating Officer | Sell | 3,695 | $34.80 | $128.6K | 0 |
| Feb 26, 2025↗ | Nichols Christian Todd | SVP, Chief Commercial Officer | Sell | 2,402 | $34.80 | $83.6K | 0 |
| Feb 26, 2025↗ | Parisi Samuel Joseph | VP, Finance (Interim PAO) | Sell | 2,746 | $34.23 | $94.0K | 0 |
| Feb 22, 2025↗ | Brown Iain Michael | SVP, Chief Financial Officer | Sell | 5,741 | $35.32 | $202.8K | 0 |
| Feb 22, 2025↗ | Gaffin David Joseph | EVP, CLO, Alkermes, Inc. | Sell | 6,714 | $35.32 | $237.1K | 0 |
| Feb 22, 2025↗ | Hopkinson Craig C. | EVP R&D, Chief Medical Officer | Sell | 8,866 | $35.32 | $313.1K | 0 |
| Feb 22, 2025↗ | Jackson Blair Curtis | EVP, Chief Operating Officer | Sell | 8,185 | $35.32 | $289.1K | 0 |
| Feb 22, 2025↗ | Nichols Christian Todd | SVP, Chief Commercial Officer | Sell | 6,003 | $35.32 | $212.0K | 0 |
| Feb 22, 2025↗ | Parisi Samuel Joseph | VP, Finance (Interim PAO) | Sell | 5,398 | $35.28 | $190.4K | 0 |
| Feb 18, 2025↗ | Brown Iain Michael | SVP, Chief Financial Officer | Sell | 1,869 | $35.90 | $67.1K | 0 |
| Feb 18, 2025↗ | Gaffin David Joseph | EVP, CLO, Alkermes, Inc. | Sell | 2,822 | $35.90 | $101.3K | 0 |
| Feb 18, 2025↗ | Hopkinson Craig C. | EVP R&D, Chief Medical Officer | Sell | 3,950 | $35.90 | $141.8K | 0 |
| Feb 18, 2025↗ | Jackson Blair Curtis | EVP, Chief Operating Officer | Sell | 3,950 | $35.90 | $141.8K | 0 |
| Feb 18, 2025↗ | Nichols Christian Todd | SVP, Chief Commercial Officer | Sell | 1,869 | $35.90 | $67.1K | 0 |
| Feb 18, 2025↗ | Parisi Samuel Joseph | VP, Finance (Interim PAO) | Sell | 2,033 | $35.76 | $72.7K | 0 |
| Feb 12, 2025↗ | Hopkinson Craig C. | EVP R&D, Chief Medical Officer | Sell | 349,340 | $33.92 | $11.85M | 0 |
| Feb 6, 2025↗ | Brown Iain Michael | SVP, Chief Financial Officer | Sell | 7,514 | $31.39 | $235.9K | 0 |
| Feb 6, 2025↗ | Gaffin David Joseph | EVP, CLO, Alkermes, Inc. | Sell | 9,752 | $31.39 | $306.1K | 0 |
| Feb 6, 2025↗ | Hopkinson Craig C. | EVP R&D, Chief Medical Officer | Sell | 15,083 | $31.39 | $473.5K | 0 |
| Feb 6, 2025↗ | Jackson Blair Curtis | EVP, Chief Operating Officer | Sell | 10,647 | $31.39 | $334.2K | 0 |
| Feb 6, 2025↗ | Nichols Christian Todd | SVP, Chief Commercial Officer | Sell | 7,399 | $31.39 | $232.3K | 0 |
| Feb 6, 2025↗ | POPS RICHARD F | Director and CEO, Alkermes plc | Sell | 79,925 | $31.39 | $2.51M | 0 |
| Jan 30, 2025↗ | Hopkinson Craig C. | EVP R&D, Chief Medical Officer | Sell | 100,918 | $32.05 | $3.23M | 0 |
| Dec 9, 2024↗ | Hopkinson Craig C. | EVP R&D, Chief Medical Officer | Sell | 61,151 | $32.07 | $1.96M | 0 |
| Dec 8, 2024↗ | LAURENCIN CATO T | Director | Sell | 3,649 | $31.75 | $115.8K | 0 |
| Dec 5, 2024↗ | Hopkinson Craig C. | EVP R&D, Chief Medical Officer | Sell | 9,221 | $31.50 | $290.5K | 0 |
| Dec 4, 2024↗ | Hopkinson Craig C. | EVP R&D, Chief Medical Officer | Sell | 14,349 | $30.77 | $441.6K | 0 |
| Nov 27, 2024↗ | Nichols Christian Todd | SVP, Chief Commercial Officer | Sell | 5,208 | $29.15 | $151.8K | 0 |
| Nov 11, 2024↗ | Hopkinson Craig C. | EVP R&D, Chief Medical Officer | Sell | 58,996 | $30.08 | $1.77M | 0 |
| Nov 6, 2024↗ | Hopkinson Craig C. | EVP R&D, Chief Medical Officer | Sell | 10,471 | $29.53 | $309.2K | 0 |
| Aug 3, 2024↗ | Gaffin David Joseph | EVP, CLO, Alkermes, Inc. | Sell | 895 | $27.72 | $24.8K | 0 |
| Jun 29, 2024↗ | Alva Emily Peterson | Director | Sell | 1,465 | $24.10 | $35.3K | 0 |
| Jun 29, 2024↗ | Cooke Shane | Director | Sell | 3,175 | $24.10 | $76.5K | 0 |
| Jun 29, 2024↗ | Daglio David Angelo Jr. | Director | Sell | 1,465 | $24.10 | $35.3K | 0 |
| Jun 29, 2024↗ | GAYNOR RICHARD | Director | Sell | 1,465 | $24.10 | $35.3K | 0 |
| Jun 29, 2024↗ | LAURENCIN CATO T | Director | Sell | 1,465 | $24.10 | $35.3K | 0 |
| Jun 29, 2024↗ | MCKEON BRIAN P | Director | Sell | 1,465 | $24.10 | $35.3K | 0 |
| Jun 29, 2024↗ | snyderman nancy lynn MD | Director | Sell | 1,465 | $24.10 | $35.3K | 0 |
| Jun 29, 2024↗ | Wilson Frank Anders | Director | Sell | 1,465 | $24.10 | $35.3K | 0 |
| Jun 29, 2024↗ | Wright Christopher I | Director | Sell | 1,465 | $24.10 | $35.3K | 0 |
| Jun 9, 2024↗ | Alva Emily Peterson | Director | Sell | 930 | $23.91 | $22.2K | 0 |
| Jun 8, 2024↗ | Wright Christopher I | Director | Sell | 793 | $23.91 | $19.0K | 0 |
| Mar 18, 2024↗ | Nichols Christian Todd | SVP, Chief Commercial Officer | Sell | 10,417 | $28.10 | $292.7K | 0 |
| Feb 23, 2024↗ | Brown Iain Michael | SVP, Chief Financial Officer | Sell | 2,587 | $29.57 | $76.5K | 0 |
| Feb 23, 2024↗ | Gaffin David Joseph | EVP, CLO, Alkermes, Inc. | Sell | 3,414 | $29.57 | $101.0K | 0 |
| Feb 23, 2024↗ | Hopkinson Craig C. | EVP R&D, Chief Medical Officer | Sell | 3,414 | $29.57 | $101.0K | 0 |
| Feb 23, 2024↗ | Jackson Blair Curtis | EVP, Chief Operating Officer | Sell | 3,880 | $29.57 | $114.7K | 0 |
| Feb 23, 2024↗ | LANDINE MICHAEL J | SVP, Corp Dev., Alkermes, Inc. | Sell | 1,811 | $29.57 | $53.6K | 0 |
| Feb 23, 2024↗ | Nichols Christian Todd | SVP, Chief Commercial Officer | Sell | 2,845 | $29.57 | $84.1K | 0 |
| Feb 23, 2024↗ | Parisi Samuel Joseph | VP, Finance (Interim PAO) | Sell | 3,231 | $29.63 | $95.7K | 0 |
| Feb 22, 2024↗ | Brown Iain Michael | SVP, Chief Financial Officer | Sell | 3,156 | $28.91 | $91.2K | 0 |
| Feb 22, 2024↗ | Gaffin David Joseph | EVP, CLO, Alkermes, Inc. | Sell | 3,300 | $28.91 | $95.4K | 0 |
| Feb 22, 2024↗ | Hopkinson Craig C. | EVP R&D, Chief Medical Officer | Sell | 5,452 | $28.91 | $157.6K | 0 |
| Feb 22, 2024↗ | Jackson Blair Curtis | EVP, Chief Operating Officer | Sell | 4,304 | $28.91 | $124.4K | 0 |
| Feb 22, 2024↗ | LANDINE MICHAEL J | SVP, Corp Dev., Alkermes, Inc. | Sell | 1,929 | $28.91 | $55.8K | 0 |
| Feb 22, 2024↗ | Nichols Christian Todd | SVP, Chief Commercial Officer | Sell | 3,156 | $28.91 | $91.2K | 0 |
| Feb 22, 2024↗ | Parisi Samuel Joseph | VP, Finance (Interim PAO) | Sell | 908 | $28.91 | $26.3K | 0 |
| Feb 18, 2024↗ | Brown Iain Michael | SVP, Chief Financial Officer | Sell | 3,594 | $31.32 | $112.6K | 0 |
| Feb 18, 2024↗ | Gaffin David Joseph | EVP, CLO, Alkermes, Inc. | Sell | 4,863 | $31.08 | $151.1K | 0 |
| Feb 18, 2024↗ | Hopkinson Craig C. | EVP R&D, Chief Medical Officer | Sell | 8,523 | $31.22 | $266.1K | 0 |
| Feb 18, 2024↗ | Jackson Blair Curtis | EVP, Chief Operating Officer | Sell | 5,966 | $31.56 | $188.3K | 0 |
| Feb 18, 2024↗ | LANDINE MICHAEL J | SVP, Corp Dev., Alkermes, Inc. | Sell | 2,914 | $31.19 | $90.9K | 0 |
| Feb 18, 2024↗ | Nichols Christian Todd | SVP, Chief Commercial Officer | Sell | 3,248 | $31.42 | $102.1K | 0 |
| Feb 18, 2024↗ | Parisi Samuel Joseph | VP, Finance (Interim PAO) | Sell | 1,347 | $31.33 | $42.2K | 0 |
| Feb 15, 2024↗ | LAURENCIN CATO T | Director | Sell | 2,690 | $31.85 | $85.7K | 0 |
| Feb 10, 2024↗ | Daglio David Angelo Jr. | Director | Sell | 1,088 | $27.32 | $29.7K | 0 |
| Feb 10, 2024↗ | MCKEON BRIAN P | Director | Sell | 1,088 | $27.32 | $29.7K | 0 |
| Feb 8, 2024↗ | Brown Iain Michael | SVP, Chief Financial Officer | Sell | 8,137 | $26.77 | $217.8K | 0 |
| Feb 8, 2024↗ | Gaffin David Joseph | EVP, CLO, Alkermes, Inc. | Sell | 8,483 | $26.77 | $227.1K | 0 |
| Feb 8, 2024↗ | Hopkinson Craig C. | EVP R&D, Chief Medical Officer | Sell | 15,280 | $26.77 | $409.0K | 0 |
| Feb 8, 2024↗ | Jackson Blair Curtis | EVP, Chief Operating Officer | Sell | 11,007 | $26.77 | $294.7K | 0 |
| Feb 8, 2024↗ | LANDINE MICHAEL J | SVP, Corp Dev., Alkermes, Inc. | Sell | 3,183 | $26.77 | $85.2K | 0 |
| Feb 8, 2024↗ | Nichols Christian Todd | SVP, Chief Commercial Officer | Sell | 8,135 | $26.77 | $217.8K | 0 |
| Feb 8, 2024↗ | POPS RICHARD F | Director and CEO, Alkermes plc | Sell | 91,757 | $26.77 | $2.46M | 0 |
| Dec 8, 2023↗ | LAURENCIN CATO T | Director | Sell | 1,000 | $25.86 | $25.9K | 0 |
| Aug 3, 2023↗ | Gaffin David Joseph | EVP, CLO, Alkermes, Inc. | Sell | 877 | $27.63 | $24.2K | 0 |
| Jul 7, 2023↗ | Alva Emily Peterson | Director | Sell | 1,430 | $29.88 | $42.7K | 0 |
| Jul 7, 2023↗ | Cooke Shane | Director | Sell | 3,098 | $29.88 | $92.6K | 0 |
| Jul 7, 2023↗ | Daglio David Angelo Jr. | Director | Sell | 1,430 | $29.88 | $42.7K | 0 |
| Jul 7, 2023↗ | GAYNOR RICHARD | Director | Sell | 1,430 | $29.88 | $42.7K | 0 |
| Jul 7, 2023↗ | LAURENCIN CATO T | Director | Sell | 1,430 | $29.88 | $42.7K | 0 |
| Jul 7, 2023↗ | MCKEON BRIAN P | Director | Sell | 1,430 | $29.88 | $42.7K | 0 |
| Jul 7, 2023↗ | snyderman nancy lynn MD | Director | Sell | 1,430 | $29.88 | $42.7K | 0 |
| Jul 7, 2023↗ | Wilson Frank Anders | Director | Sell | 1,430 | $29.88 | $42.7K | 0 |
| Jul 7, 2023↗ | Wright Christopher I | Director | Sell | 1,430 | $29.88 | $42.7K | 0 |
| Jul 7, 2023↗ | Wysenski Nancy | Director | Sell | 1,430 | $29.88 | $42.7K | 0 |
| Jun 9, 2023↗ | Alva Emily Peterson | Director | Sell | 911 | $31.13 | $28.4K | 0 |
| Jun 8, 2023↗ | LAURENCIN CATO T | Director | Sell | 2,638 | $31.85 | $84.0K | 0 |
| Jun 8, 2023↗ | Wright Christopher I | Director | Sell | 867 | $31.54 | $27.3K | 0 |
| Jun 7, 2023↗ | LAURENCIN CATO T | Director | Sell | 2,800 | $31.50 | $88.2K | 0 |
| Jun 5, 2023↗ | Nichols Christian Todd | SVP, Chief Commercial Officer | Sell | 1,555 | $29.46 | $45.8K | 0 |
| May 30, 2023↗ | Nichols Christian Todd | SVP, Chief Commercial Officer | Sell | 27,134 | $28.93 | $784.9K | 0 |
| May 9, 2023↗ | Wysenski Nancy | Director | Sell | 41,250 | $31.24 | $1.29M | 0 |
| Feb 22, 2023↗ | Brown Iain Michael | SVP, Chief Financial Officer | Sell | 2,049 | $27.77 | $56.9K | 0 |
| Feb 22, 2023↗ | Gaffin David Joseph | EVP, CLO, Alkermes, Inc. | Sell | 3,224 | $27.77 | $89.5K | 0 |
| Feb 22, 2023↗ | Hopkinson Craig C. | EVP R&D, Chief Medical Officer | Sell | 5,345 | $27.77 | $148.4K | 0 |
| Feb 22, 2023↗ | Jackson Blair Curtis | EVP, Chief Operating Officer | Sell | 3,088 | $27.77 | $85.8K | 0 |
| Feb 22, 2023↗ | LANDINE MICHAEL J | SVP, Corp Dev., Alkermes, Inc. | Sell | 2,462 | $27.77 | $68.4K | 0 |
| Feb 22, 2023↗ | Nichols Christian Todd | SVP, Chief Commercial Officer | Sell | 2,704 | $27.77 | $75.1K | 0 |
| Feb 20, 2023↗ | POPS RICHARD F | Director and CEO, Alkermes plc | Sell | 67,531 | $28.01 | $1.89M | 0 |
| Feb 18, 2023↗ | Brown Iain Michael | SVP, Chief Financial Officer | Sell | 7,693 | $28.01 | $215.5K | 0 |
| Feb 18, 2023↗ | Gaffin David Joseph | EVP, CLO, Alkermes, Inc. | Sell | 10,584 | $28.01 | $296.5K | 0 |
| Feb 18, 2023↗ | Hopkinson Craig C. | EVP R&D, Chief Medical Officer | Sell | 16,015 | $28.01 | $448.6K | 0 |
| Feb 18, 2023↗ | Jackson Blair Curtis | EVP, Chief Operating Officer | Sell | 8,411 | $28.02 | $235.7K | 0 |
| Feb 18, 2023↗ | LANDINE MICHAEL J | SVP, Corp Dev., Alkermes, Inc. | Sell | 12,256 | $28.01 | $343.3K | 0 |
| Feb 18, 2023↗ | Nichols Christian Todd | SVP, Chief Commercial Officer | Sell | 9,839 | $28.07 | $276.2K | 0 |
| Dec 8, 2022↗ | LAURENCIN CATO T | Director | Sell | 763 | $25.48 | $19.4K | 0 |
| Jun 21, 2022↗ | Nichols Christian Todd | SVP, Chief Commercial Officer | Sell | 7,474 | $28.26 | $211.2K | 0 |
| Jun 14, 2022↗ | Alva Emily Peterson | Director | Sell | 905 | $27.19 | $24.6K | 0 |
| Jun 14, 2022↗ | Cooke Shane | Director | Sell | 3,945 | $27.19 | $107.3K | 0 |
| Jun 14, 2022↗ | Daglio David Angelo Jr. | Director | Sell | 795 | $27.19 | $21.6K | 0 |
| Jun 14, 2022↗ | GAYNOR RICHARD | Director | Sell | 695 | $27.19 | $18.9K | 0 |
| Jun 14, 2022↗ | MCKEON BRIAN P | Director | Sell | 795 | $27.19 | $21.6K | 0 |
| Jun 14, 2022↗ | snyderman nancy lynn MD | Director | Sell | 695 | $27.19 | $18.9K | 0 |
| Jun 14, 2022↗ | Wilson Frank Anders | Director | Sell | 695 | $27.19 | $18.9K | 0 |
| Jun 14, 2022↗ | Wysenski Nancy | Director | Sell | 695 | $27.19 | $18.9K | 0 |
| Jun 9, 2022↗ | Alva Emily Peterson | Director | Sell | 347 | $28.13 | $9.8K | 0 |
| Jun 5, 2022↗ | Nichols Christian Todd | SVP, Chief Commercial Officer | Sell | 1,029 | $29.31 | $30.2K | 0 |
| May 17, 2022↗ | LANDINE MICHAEL J | SVP, Corp Dev., Alkermes, Inc. | Sell | 50,000 | $29.15 | $1.46M | 0 |
| May 10, 2022↗ | LANDINE MICHAEL J | SVP, Corp Dev., Alkermes, Inc. | Sell | 25,000 | $27.22 | $680.4K | 0 |
| May 5, 2022↗ | POPS RICHARD F | Director and CEO, Alkermes plc | Sell | 347,257 | $27.98 | $9.72M | 0 |
| May 3, 2022↗ | LANDINE MICHAEL J | SVP, Corp Dev., Alkermes, Inc. | Sell | 25,000 | $28.62 | $715.4K | 0 |
| May 2, 2022↗ | Cooke Shane | Director | Sell | 10,000 | $29.23 | $292.3K | 0 |
| Apr 25, 2022↗ | Cooke Shane | Director | Sell | 10,000 | $27.88 | $278.8K | 0 |
| Apr 20, 2022↗ | Jackson Blair Curtis | EVP, Chief Operating Officer | Sell | 49,999 | $29.61 | $1.48M | 0 |
| Apr 18, 2022↗ | Cooke Shane | Director | Sell | 10,000 | $28.88 | $288.8K | 0 |
| Apr 11, 2022↗ | Cooke Shane | Director | Sell | 10,000 | $29.26 | $292.6K | 0 |
| Apr 4, 2022↗ | Cooke Shane | Director | Sell | 10,000 | $28.18 | $281.8K | 0 |
| Feb 23, 2022↗ | Hopkinson Craig C. | EVP R&D, Chief Medical Officer | Sell | 11,983 | $24.76 | $296.6K | 0 |
| Feb 18, 2022↗ | Brown Iain Michael | SVP, Chief Financial Officer | Sell | 4,809 | $25.05 | $120.5K | 0 |
| Feb 18, 2022↗ | Gaffin David Joseph | SVP, CLO, Alkermes, Inc. | Sell | 6,226 | $25.06 | $156.0K | 0 |
| Feb 18, 2022↗ | Hopkinson Craig C. | EVP R&D, Chief Medical Officer | Sell | 10,833 | $25.08 | $271.7K | 0 |
| Feb 18, 2022↗ | Jackson Blair Curtis | EVP, Chief Operating Officer | Sell | 5,541 | $25.04 | $138.8K | 0 |
| Feb 18, 2022↗ | LANDINE MICHAEL J | SVP, Corp Dev., Alkermes, Inc. | Sell | 7,417 | $25.06 | $185.8K | 0 |
| Feb 18, 2022↗ | Nichols Christian Todd | SVP, Chief Commercial Officer | Sell | 3,293 | $25.04 | $82.4K | 0 |
| Feb 18, 2022↗ | POPS RICHARD F | Director and CEO, Alkermes plc | Sell | 14,386 | $25.08 | $360.8K | 0 |
| Feb 16, 2022↗ | Brown Iain Michael | SVP, Chief Financial Officer | Sell | 825 | $26.79 | $22.1K | 0 |
| Feb 16, 2022↗ | Gaffin David Joseph | SVP, CLO, Alkermes, Inc. | Sell | 1,098 | $26.79 | $29.4K | 0 |
| Feb 16, 2022↗ | Hopkinson Craig C. | EVP R&D, Chief Medical Officer | Sell | 1,069 | $26.79 | $28.6K | 0 |
| Feb 16, 2022↗ | Jackson Blair Curtis | EVP, Chief Operating Officer | Sell | 825 | $26.79 | $22.1K | 0 |
| Feb 16, 2022↗ | LANDINE MICHAEL J | SVP, Corp Dev., Alkermes, Inc. | Sell | 1,620 | $26.79 | $43.4K | 0 |
| Feb 16, 2022↗ | POPS RICHARD F | Director and CEO, Alkermes plc | Sell | 8,038 | $26.79 | $215.3K | 0 |
| Feb 10, 2022↗ | Daglio David Angelo Jr. | Director | Sell | 2,735 | $23.55 | $64.4K | 0 |
| Feb 10, 2022↗ | MCKEON BRIAN P | Director | Sell | 2,735 | $23.55 | $64.4K | 0 |
| Dec 2, 2021↗ | ANSTICE DAVID W | Director | Sell | 1,339 | $22.11 | $29.6K | 0 |
| Dec 2, 2021↗ | Cooke Shane | Director | Sell | 2,901 | $22.11 | $64.1K | 0 |
| Dec 2, 2021↗ | DIXON WENDY L | Director | Sell | 1,339 | $22.11 | $29.6K | 0 |
| Dec 2, 2021↗ | GAYNOR RICHARD | Director | Sell | 1,339 | $22.11 | $29.6K | 0 |
| Dec 2, 2021↗ | snyderman nancy lynn MD | Director | Sell | 1,339 | $22.11 | $29.6K | 0 |
| Dec 2, 2021↗ | Wilson Frank Anders | Director | Sell | 1,339 | $22.11 | $29.6K | 0 |
| Dec 2, 2021↗ | Wysenski Nancy | Director | Sell | 1,339 | $22.11 | $29.6K | 0 |
| Sep 14, 2021↗ | Brown Iain Michael | SVP, Chief Financial Officer | Sell | 3,057 | $30.60 | $93.5K | 0 |
| Sep 14, 2021↗ | Gaffin David Joseph | SVP, CLO, Alkermes, Inc. | Sell | 4,634 | $30.60 | $141.8K | 0 |
| Sep 14, 2021↗ | Hopkinson Craig C. | EVP R&D, Chief Medical Officer | Sell | 5,647 | $30.60 | $172.8K | 0 |
| Sep 14, 2021↗ | Jackson Blair Curtis | EVP, Chief Operating Officer | Sell | 2,024 | $30.60 | $61.9K | 0 |
| Sep 14, 2021↗ | LANDINE MICHAEL J | SVP, Corp Dev., Alkermes, Inc. | Sell | 3,566 | $30.60 | $109.1K | 0 |
| Sep 14, 2021↗ | Nichols Christian Todd | SVP, Chief Commercial Officer | Sell | 4,608 | $30.60 | $141.0K | 0 |
| Sep 14, 2021↗ | POPS RICHARD F | Director and CEO, Alkermes plc | Sell | 36,267 | $30.60 | $1.11M | 0 |
| Aug 19, 2021↗ | Brown Iain Michael | SVP, Chief Financial Officer | Sell | 40,000 | $29.99 | $1.20M | 0 |
| Jul 29, 2021↗ | Gaffin David Joseph | SVP, CLO, Alkermes, Inc. | Sell | 14,000 | $26.00 | $364.0K | 0 |
| Jul 1, 2021↗ | ANSTICE DAVID W | Director | Sell | 20,000 | $24.58 | $491.5K | 0 |
| Jun 10, 2021↗ | DIXON WENDY L | Director | Sell | 25,000 | $25.00 | $625.0K | 0 |
| Jun 10, 2021↗ | Gaffin David Joseph | SVP, CLO, Alkermes, Inc. | Sell | 13,500 | $25.00 | $337.5K | 0 |
| Jun 9, 2021↗ | Hopkinson Craig C. | EVP R&D, Chief Medical Officer | Sell | 882 | $24.60 | $21.7K | 0 |
| Jun 7, 2021↗ | ANSTICE DAVID W | Director | Sell | 5,000 | $24.00 | $120.0K | 0 |
| Jun 7, 2021↗ | Gaffin David Joseph | SVP, CLO, Alkermes, Inc. | Sell | 13,500 | $24.00 | $324.0K | 0 |
| Jun 7, 2021↗ | Hopkinson Craig C. | EVP R&D, Chief Medical Officer | Sell | 368 | $23.50 | $8.6K | 0 |
| Jun 5, 2021↗ | Nichols Christian Todd | SVP, Chief Commercial Officer | Sell | 1,029 | $23.08 | $23.7K | 0 |
| May 20, 2021↗ | ANSTICE DAVID W | Director | Sell | 1,404 | $21.92 | $30.8K | 0 |
| May 20, 2021↗ | BREYER ROBERT A | Director | Sell | 2,930 | $21.92 | $64.2K | 0 |
| May 20, 2021↗ | Cooke Shane | Director | Sell | 3,175 | $21.92 | $69.6K | 0 |
| May 20, 2021↗ | DIXON WENDY L | Director | Sell | 1,404 | $21.92 | $30.8K | 0 |
| May 20, 2021↗ | GAYNOR RICHARD | Director | Sell | 1,404 | $21.92 | $30.8K | 0 |
| May 20, 2021↗ | MITCHELL PAUL J | Director | Sell | 2,930 | $21.92 | $64.2K | 0 |
| May 20, 2021↗ | snyderman nancy lynn MD | Director | Sell | 1,404 | $21.92 | $30.8K | 0 |
| May 20, 2021↗ | Wilson Frank Anders | Director | Sell | 1,404 | $21.92 | $30.8K | 0 |
| May 20, 2021↗ | Wysenski Nancy | Director | Sell | 1,404 | $21.92 | $30.8K | 0 |
| May 18, 2021↗ | POPS RICHARD F | Director and CEO, Alkermes plc | Sell | 150,000 | $21.90 | $3.29M | 0 |
| May 17, 2021↗ | LANDINE MICHAEL J | SVP, Corp Dev., Alkermes, Inc. | Sell | 50,000 | $22.09 | $1.10M | 0 |
| May 14, 2021↗ | Gaffin David Joseph | SVP, CLO, Alkermes, Inc. | Sell | 2,250 | $22.23 | $50.0K | 0 |
| May 13, 2021↗ | LANDINE MICHAEL J | SVP, Corp Dev., Alkermes, Inc. | Sell | 25,000 | $22.39 | $559.7K | 0 |
| May 11, 2021↗ | POPS RICHARD F | Director and CEO, Alkermes plc | Sell | 150,000 | $22.09 | $3.31M | 0 |
| May 7, 2021↗ | LANDINE MICHAEL J | SVP, Corp Dev., Alkermes, Inc. | Sell | 19,477 | $22.10 | $430.5K | 0 |
| May 6, 2021↗ | POPS RICHARD F | Director and CEO, Alkermes plc | Sell | 100,000 | $21.79 | $2.18M | 0 |
| May 3, 2021↗ | Jackson Blair Curtis | EVP, Chief Operating Officer | Sell | 34,503 | $22.18 | $765.2K | 0 |
| Apr 19, 2021↗ | DIXON WENDY L | Director | Sell | 25,000 | $20.00 | $500.1K | 0 |
| Apr 16, 2021↗ | Brown Iain Michael | SVP, Chief Financial Officer | Sell | 35,000 | $20.00 | $699.9K | 0 |
| Apr 15, 2021↗ | Hopkinson Craig C. | EVP R&D, Chief Medical Officer | Sell | 28,920 | $19.72 | $570.3K | 0 |
| Feb 21, 2021↗ | POPS RICHARD F | Director and CEO, Alkermes plc | Sell | 14,386 | $19.58 | $281.7K | 0 |
| Feb 20, 2021↗ | Brown Iain Michael | SVP, Chief Financial Officer | Sell | 2,790 | $19.58 | $54.6K | 0 |
| Feb 20, 2021↗ | Gaffin David Joseph | SVP, CLO, Alkermes, Inc. | Sell | 4,083 | $19.58 | $79.9K | 0 |
| Feb 20, 2021↗ | Hopkinson Craig C. | EVP R&D, Chief Medical Officer | Sell | 5,086 | $19.58 | $99.6K | 0 |
| Feb 20, 2021↗ | Jackson Blair Curtis | EVP, Chief Operating Officer | Sell | 2,786 | $19.58 | $54.5K | 0 |
| Feb 20, 2021↗ | LANDINE MICHAEL J | SVP, Corp Dev., Alkermes, Inc. | Sell | 4,947 | $19.58 | $96.9K | 0 |
| Feb 20, 2021↗ | Nichols Christian Todd | SVP, Chief Commercial Officer | Sell | 1,292 | $19.58 | $25.3K | 0 |
ALKS Insiders
Similar Stocks to ALKS
VRTX
Vertex Pharmaceuticals Incorporated
$470.20-1.66%
$121.44B
REGN
Regeneron Pharmaceuticals, Inc.
$743.51-0.41%
$77.57B
ALNY
Alnylam Pharmaceuticals, Inc.
$313.45-1.19%
$42.07B
INSM
Insmed Incorporated
$139.06-0.33%
$30.07B
UTHR
United Therapeutics Corporation
$538.00+0.97%
$21.50B
INCY
Incyte Corporation
$92.25+0.27%
$20.10B
RVMD
Revolution Medicines, Inc.
$95.44+0.39%
$20.10B
MRNA
Moderna, Inc.
$52.38-1.89%
$19.96B